DuPont
Executive Summary
Former Searle CEO Richard De Schutter is named DuPont Pharmaceuticals chairman. De Schutter was appointed chief administrative officer of Pharmacia when Monsanto merged with Pharmacia & Upjohn in April, and his retirement from the newly merged company was announced in May. Pharmacia said no plans have been made for a replacement. The position of chairman has been vacant since former DuPont Pharmaceuticals Chairman & CEO Kurt Landgraf left the company in May. Nicholas Teti was named new CEO. Teti and De Schutter report to DuPont Chairman Charles Holiday
You may also be interested in...
Pharmacia North America Rx President Is Spiers; Hassan Adds Chairman Title
Pharmacia North American Pharmaceuticals President Mark Spiers will lead the company's search for a new head of U.S. sales.
Pharmacia North America Rx President Is Spiers; Hassan Adds Chairman Title
Pharmacia North American Pharmaceuticals President Mark Spiers will lead the company's search for a new head of U.S. sales.
DuPont Spinning Off Rx Business As Cozaar Profit-Share Trigger Nears
DuPont's handling of the profit-sharing agreement for Cozaar is a central consideration in the valuing of the company's planned prescription drug spin-off.